PetVivo Holdings, Inc. (PETV) Research
PetVivo Holdings, Inc. operates as a biomedical technology firm, specializing in the invention, commercialization, and licensing of advanced medical devices and biomaterials intended to treat a variety of ailments and diseases affecting animals. Its flagship product is Spryng, an intra-articular injection administered by veterinarians to effectively alleviate lameness and joint conditions, such as osteoarthritis, in canines and equines. The company's development pipeline further includes seventeen therapeutic devices poised for both veterinary and human clinical applications. Founded in 2009, PetVivo Holdings, Inc. maintains its corporate headquarters in Minneapolis, Minnesota.
Market snapshot
- Symbol
- PETV
- Price
- $0.80
- Day change
- +2.56%
- Market cap
- $21.7M
- P/E ratio
- -2.71x
- 52-week range
- 0.6-1.69
- Sector
- Healthcare
- Industry
- Medical - Devices
- Next earnings
- in 6 days
Peer companies
Recent insider activity
- A.L. Sarroff Fund, LLC — P-Purchase (187500 shares) on 2026-06-09
- A.L. Sarroff Fund, LLC — P-Purchase (187500 shares) on 2026-06-09
- A.L. Sarroff Fund, LLC — G-Gift (200000 shares) on 2026-05-28
- A.L. Sarroff Fund, LLC — P-Purchase (250000 shares) on 2026-05-22
- LOWENTHAL GARRY N — A-Award (66421 shares) on 2026-05-15
Open PetVivo Holdings, Inc. (PETV) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.